GRAIL Presents Interventional PATHFINDER Study Data and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test June 4, 2021
Pulmocide Raises $92 Million in a Series C Financing to Fund Registration Program for PC945 May 27, 2021
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases May 25, 2021
